Cellectar Biosciences, Inc. - Common Shares (CLRB)

Historical Holders from Q2 2025 to Q3 2025

Type / Class
Equity / Common Shares
Symbol
CLRB on Nasdaq
Shares outstanding
3,289,474
Price per share
$5.60
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
296,154
Total reported value
$1,650,372
% of total 13F portfolios
0%
Share change
+192,757
Value change
+$1,061,105
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
21
Price from insider filings
$3.70
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellectar Biosciences, Inc. - Common Shares (CLRB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Bleichroeder LP 6.1% $1,120,000 200,000 Bleichroeder LP 30 Sep 2025
Hexstone Capital LLC 5.6% $732,000 150,000 Hexstone Capital LLC 02 Jul 2025
INTRACOASTAL CAPITAL, LLC 5% 140,101 Mitchell P. Kopin 01 Jul 2025
LYTTON LAURENCE W 1.6% $250,788 51,391 LYTTON LAURENCE W 30 Jun 2025
Nantahala Capital Management, LLC 0.06% $5,412 1,109 Nantahala Capital Management, LLC 30 Jun 2025
As of 30 Sep 2025, Cellectar Biosciences, Inc. - Common Shares (CLRB) has 21 institutional shareholders filing 13F forms. They hold 296,154 shares. of 3,289,474 outstanding shares (9%) .

Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 296,154 $1,650,372 +$1,061,105 560% 21
2025 Q2 103,397 $734,048 +$734,048 710.71% 19